Holen Sie sich die Stockscreener-App
22.77
4.35%
-1.00
Handel nachbörslich:
22.77
Schlusskurs vom Vortag:
$23.77
Offen:
$23.755
24-Stunden-Volumen:
1.84M
Relative Volume:
0.68
Marktkapitalisierung:
$1.96B
Einnahmen:
$17.49M
Nettoeinkommen (Verlust:
$-78.50M
KGV:
-18.98
EPS:
-1.2
Netto-Cashflow:
$-52.85M
1W Leistung:
-5.37%
1M Leistung:
-12.52%
6M Leistung:
+64.39%
1J Leistung:
+104.18%
1-Tages-Spanne:
$22.39
$23.84
1-Wochen-Bereich:
$22.39
$25.12
52-Wochen-Spanne:
$9.71
$29.94
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Vergleichen Sie LQDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
22.77 | 2.00B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
What sentiment indicators say about Liquidia Corporation stockFed Meeting & Daily Risk Controlled Trade Plans - newser.com
Is Liquidia Corporation showing signs of accumulationFed Meeting & Technical Pattern Alert System - newser.com
Real time alert setup for Liquidia Corporation performanceQuarterly Trade Review & AI Based Buy and Sell Signals - newser.com
Liquidia Technologies (NASDAQ:LQDA) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Bank of America Securities Sticks to Their Buy Rating for Liquidia Technologies (LQDA) - The Globe and Mail
Liquidia Corporation’s volatility index tracking explained2025 Market Overview & Weekly High Return Opportunities - newser.com
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 - The Manila Times
Oct. 28 R&D Day — Liquidia to present L606 sustained‑release and YUTREPIA clinical update; webcast - Stock Titan
HC Wainwright Reaffirms Buy Rating for Liquidia Technologies (NASDAQ:LQDA) - MarketBeat
LQDA: HC Wainwright Reiterates Buy Rating with $35 PT | LQDA Sto - GuruFocus
What machine learning models say about Liquidia CorporationJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com
Can Liquidia Corporation (LT4) stock ride next bull market cycleJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Liquidia (LQDA): Evaluating Valuation After Positive Tyvaso Results Shift Pulmonary Treatment Landscape - simplywall.st
Liquidia Corporation Stock Analysis and ForecastVolatility Trading Techniques & Stocks to Buy Before Earnings Season - earlytimes.in
Analyzing drawdowns of Liquidia Corporation with statistical tools2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Will Liquidia Corporation rebound enough to break evenJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
Combining machine learning predictions for Liquidia CorporationDividend Hike & Smart Money Movement Alerts - newser.com
Is Liquidia Corporation (LT4) stock a top dividend aristocrat candidateJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Will Liquidia Corporation stock outperform value stocksPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Will Liquidia Corporation (LT4) stock sustain uptrend momentumWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
UTC, Liquidia Clash on Xarelto Patent Ruling’s Tyvaso Impact - Bloomberg Law News
Is Liquidia Corporation (LT4) stock prepared for digital transitionQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth - simplywall.st
What’s the recovery path for long term holders of Liquidia CorporationWeekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Breaking PH-ILD Research: Liquidia's LIQ861 16-Week Trial Data to be Revealed at Major CHEST Conference - Stock Titan
Multi asset correlation models including Liquidia CorporationJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting - Yahoo Finance
Is Liquidia Corporation stock attractive for income investors2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Liquidia Corporation (LQDA) Presents Strategic Overview at Well Fargo’s Annual Healthcare Conference 2025 - Yahoo Finance
Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares? - Yahoo Finance
Institutional investors in Liquidia Corporation (NASDAQ:LQDA) lost 8.5% last week but have reaped the benefits of longer-term growth - Yahoo Finance
Insider Selling: Liquidia Technologies (NASDAQ:LQDA) Director Sells 45,524 Shares of Stock - MarketBeat
Exit strategy if you’re trapped in Liquidia CorporationMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Should you hold or exit Liquidia Corporation nowWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
How to monitor Liquidia Corporation with trend dashboards2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
Predicting Liquidia Corporation trend using moving averagesJuly 2025 Opening Moves & Free Weekly Watchlist of Top Performers - newser.com
Historical volatility pattern of Liquidia Corporation visualizedTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
Tools to monitor Liquidia Corporation recovery probabilityQuarterly Portfolio Report & Expert Approved Momentum Trade Ideas - newser.com
Sentiment Watch: Can WideOpenWest Inc. sustain earnings growthAnalyst Upgrade & Free Technical Confirmation Trade Alerts - خودرو بانک
Liquidia Corporation (LQDA): A Bull Case Theory - Yahoo Finance
Risk Hedge: Does Liquidia Corporation have strong EBITDA marginsVolume Spike & Daily Chart Pattern Signals - khodrobank.com
Bluefin Capital Management LLC Invests $250,000 in Liquidia Technologies, Inc. $LQDA - MarketBeat
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium - The Manila Times
Liquidia Corporation to Present New Data on LIQ861 at Pulmonary Hypertension Professional Association Symposium - Quiver Quantitative
Breaking PH-ILD Treatment Data: Liquidia's YUTREPIA Shows New Safety Results in ASCENT Trial at PHPN - Stock Titan
Boothbay Fund Management LLC Boosts Holdings in Liquidia Technologies, Inc. $LQDA - MarketBeat
Jefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA) - MSN
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Liquidia Corp-Aktie (LQDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SINGH RAMAN | Director |
Sep 15 '25 |
Sale |
25.81 |
45,524 |
1,174,974 |
31,255 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):